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ADDRESSING PHYSICIAN ASSISTANT STUDENT STIGMA TOWARD 
SUBSTANCE USE DISORDERS  
MARION TILEARCIO 
ABSTRACT 
Background 
Substance use disorders are highly prevalent and highly stigmatized. They are defined as 
conditions in which the use of one or more substances, in spite of negative consequences, 
leads to a clinically significant impairment or distress. Stigma is a characteristic deemed 
undesirable by society. Stigma is dependent on the relationship between the specific 
discrediting or undesirable characteristic and the social context.  
Literature review findings 
The various manifestations of stigma include public or external stigma, provider stigma, 
and internal stigma. External stigma is the negative beliefs that society holds about 
people in stigmatized groups, for example patients with substance use disorders or HIV. 
Another type of stigma is provider stigma, referring to the negative beliefs that providers 
hold about patients belonging to these stigmatized groups. Internal stigma is defined as 
the devaluation that people in stigmatized groups hold about themselves in relation to 
society. Stigma is continued when there is a lack of familiarity and education with a 
stigmatized condition or group.  
Proposed project 
The proposed project aims to address and decrease provider stigma in physician assistant 
trainees before they begin their clinical training through an educational intervention. This 
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thesis will propose the development and evaluation of a new curriculum to educate 
physician assistant students on substance use disorders and their treatments, frame 
substance use disorders as chronic diseases, and aid physician assistant student trainees 
on recognizing their attitudes and biases, or prejudices, toward working with patients 
with substance use disorders. The project will assess attitudes before and after the 
education intervention to analyze if attitudes toward patients with substance use disorders 
have changed as a result of the educational intervention. The goal of the educational 
curriculum is to improve physician assistant student attitudes toward working with 
patients with substance use disorders before they encounter this population in clinical 
practice.  
Significance 
Physician assistants are clinicians who diagnose illness, develop treatment plans, manage 
their own patients, and often serve as the primary clinician for patients. Physician 
assistants will encounter a number of patients with substance use disorders throughout the 
course of their careers. Addressing provider stigma in this group will help improve 
treatment outcomes in this patient population and give the students the confidence and 
knowledge to manage patients with substance use disorders. As a result of completing 
this curriculum, physician assistant students will have decreased stigma and better 
attitudes toward working with patients with substance use disorders.   
 	    
	  	   vii 
TABLE OF CONTENTS 
 
TITLE……………………………………………………………………………………...i 
COPYRIGHT PAGE……………………………………………………………………...ii 
READER APPROVAL PAGE…………………………………………………………..iii 
ACKNOWLEDGMENTS ................................................................................................. iv	  
ABSTRACT ........................................................................................................................ v	  
TABLE OF CONTENTS .................................................................................................. vii	  
LIST OF TABLES ............................................................................................................. ix	  
LIST OF FIGURES ............................................................................................................ x	  
LIST OF ABBREVIATIONS ............................................................................................ xi	  
INTRODUCTION .............................................................................................................. 1	  
Background ..................................................................................................................... 1	  
Statement of the Problem ................................................................................................ 3	  
Hypothesis....................................................................................................................... 4	  
Objectives and specific aims ........................................................................................... 4	  
REVIEW OF THE LITERATURE .................................................................................... 6	  
Overview ......................................................................................................................... 6	  
Existing research ........................................................................................................... 15	  
METHODS ....................................................................................................................... 23	  
	  	   viii 
Study design .................................................................................................................. 23	  
Study population and sampling ..................................................................................... 23	  
Intervention ................................................................................................................... 24	  
Study variables and measures ....................................................................................... 26	  
Recruitment ................................................................................................................... 26	  
Data collection .............................................................................................................. 26	  
Data analysis ................................................................................................................. 26	  
Timeline and resources ................................................................................................. 27	  
Institutional Review Board ........................................................................................... 28	  
CONCLUSION ................................................................................................................. 29	  
Discussion ..................................................................................................................... 29	  
Summary ....................................................................................................................... 30	  
Clinical and/or public health significance ..................................................................... 31	  
APPENDIX ....................................................................................................................... 32	  
LIST OF JOURNAL ABBREVIATIONS ....................................................................... 35	  
REFERENCES ................................................................................................................. 37	  
CURRICULUM VITAE ................................................................................................... 41	  
 
  
	  	   ix 
LIST OF TABLES 
 
 
Table Title Page 
1 Components of Public Stigma 2 
2 Psychoactive drugs and their receptors in the brain 6 
4 Timeline for the Substance Use Disorders and Associated 
Stigma Curriculum 
27 
5 Budget for the Substance Use and Associated Stigma 
Curriculum 
27 
 
 
  
	  	   x 
LIST OF FIGURES 
 
 
 
Figure Title Page 
1 Opioid Related Deaths January 2000-June 2016 9 
2 Path models to discrimination, taken from Corrigan et. al, 
2001 
13 
3 Theoretical path model of familiarity, taken from Janulis 
et. al 2013 
14 
4 Substance Use Disorders and Associated Stigma 
Intervention Design 
24 
 
 
  
	  	   xi 
LIST OF ABBREVIATIONS 
 
BU ............................................................................................................ Boston University 
HCV ........................................................................................................... Hepatitis C Virus 
HIV ................................................................................... Human Immunodeficiency Virus 
IDUs ........................................................................................................ Injection Drug Use 
PA ......................................................................................................... Physician Assistant 
 
PWID ............................................................................................ People Who Inject Drugs 
SAAS ............................................................................... Substance Abuse Attitude Survey 
SUD ................................................................................................ Substance Use Disorder 
 
 
 
	  1 
INTRODUCTION 
Background 
Substance use disorders are highly prevalent and highly stigmatized. In 2015, an 
estimated 20.8 million persons aged 12 or older were classified with substance use 
disorder in the USA.1 Substance use disorder is defined as a condition in which the use of 
one or more substances, in spite of negative consequences, leads to a clinically significant 
impairment or distress.2 Substance use disorders are in a unique category of disease 
processes. Because they are viewed less as chronic disease processes by some and more 
as illicit activity, they have a very unique stigma. 
Stigma is defined as a mark-signifying deviance and by the presence of a deeply 
discrediting attribute.3,4 Stigma is a characteristic deemed undesirable by society. Stigma 
is dependent on the relationship between the specific discrediting attribute and the 
specific social context; meaning that a particular characteristic may not me considered 
stigmatizing in all situations but is directly tied to a specific social context.5 There are a 
number of manifestations of stigma, although the goal of this study is to examine and 
reduce the process of stigma from a clinician toward patients with substance use 
disorders, also known as provider stigma. Public or external stigma includes the negative 
beliefs individuals in society have about people in stigmatized groups, for example 
patients with substance use disorders or HIV. Public stigma encompasses stereotypes, 
prejudices or biases, and discrimination. Biases or prejudices are negative thoughts that 
one agrees to be true about a particular subject.6 Discrimination is the behavior response 
to prejudice, which results in negative outcomes for the person being stigmatized, in the 
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case of a patient with substance use disorder, for example, shame, guilt, avoidance, and 
thus failure to seek treatment. Table 1 summarizes key definitions in the understanding of 
public or external stigma. 
Table 1: Components of Public Stigma, adapted from Corrigan et. al 2002 
Term Definition 
Stereotype Belief about a group 
Prejudice or 
bias 
Agreement with belief and/or negative emotional reaction 
Discrimination Behavior response to prejudice 
 
Physician Assistants (PA) practice in a variety of settings and the ability to 
recognize and treat substance use disorders and treat affected people with empathy is 
crucial to effective health care delivery with this population.  Many studies highlight that 
clinicians’ bias toward patients with substance use disorders affect the quality of 
treatment provided to this population.7,8 Patients who feel marginalized or stigmatized are 
more likely to relapse or avoid treatment.9,10 Several studies demonstrated inadequate 
training and education on substance use disorders impacted health professionals’ attitudes 
toward patients with substance use disorders.  This led to inadequacy in both knowledge 
and skills to manage these patients.9–13 It has also been suggested that familiarity with 
stigmatized conditions reduces negative attitudes toward these populations.5,14 
Physician Assistants diagnose illness, develop treatment plans, manage their own 
patients, and often serve as the primary clinician for patients.15 Given the scope of 
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practice of Physician Assistants and the prevalence of substance use disorders, it is 
important that these clinicians are educated on addiction and associated stigma to help 
minimize clinician bias and stigma toward these patients. Preemptively educating PA 
students could also improve patient-provider interactions in this population. As it stands 
now, many programs provide lectures on substance use disorders but do not highlight 
how stigma toward these patients could affect their decision to seek care. A 
comprehensive curriculum including education on substance use disorders and stigma 
could help decrease the stigmatization of these disorders and improve healthcare delivery 
in this patient population.   
 
Statement of the Problem 
Many studies demonstrate that lack of training and education about substance use 
disorders contributes to the stigmatization of these conditions.9–13 Lack of education and 
training also leads to feelings of inadequacy and negative attitudes toward working with 
patients with substance use disorders. Educating PA students during their didactic year 
about substance addiction as a chronic disease could help decrease negative attitudes 
toward working with this population. Assessing the prejudices of students before they 
begin their clinical training and before they begin this curriculum could help identify and 
address potential sources of stigma before the students interact with these patients. 
Current PA programs’ curricula include lectures on addiction, substance use 
disorders, and safer opioid prescription strategies. Although substance use disorders are 
covered in lectures, PA students could be more familiar with the topic before entering the 
clinical realm. Programs do not focus on preventing stigma or analyzing student attitudes 
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toward working with patients with substance use disorders before they begin their clinical 
year of education. Stigma and discrimination are propagated when there is a lack of 
familiarity with a given condition.5,14 Ultimately, bolstering PA students’ education about 
addiction could mitigate negative biases toward patients with these diagnoses.    
 
Hypothesis 
An educational program for PA students will lead to positive attitudes and decreased 
stigma toward working with patients with substance use disorders  
 
Objectives and specific aims 
As part of integrating a novel curriculum for teaching PA students about substance use 
disorders, their treatments, and associated stigma, PA students will learn to recognize 
substance use disorders as chronic diseases. They will become more familiar with 
substance use disorders to minimize stigma. Learners will be educated on what stigma is 
and how it can manifest. To evaluate the effectiveness of this intervention, they will have 
assessments on their attitudes pre and post education module. This educational module 
will help students recognize their own attitudes and societal stigma toward patients with 
substance use disorders.  
The study’s specifics aims are to:  
1. Enhance PA student knowledge regarding substance use disorders, their 
treatments, and their associated stigma. 
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2. Measure PA students’ change in attitude and knowledge about substance use 
disorders before and after the curriculum 
3. Obtain student feedback to optimize the curriculum intervention 
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REVIEW OF THE LITERATURE 
Overview 
Substance use disorder is defined as a condition in which the use of one or more 
substances leads to a clinically significant impairment or distress.2 Substances include 
psychoactive drugs that alter mood, consciousness, or perception of reality (Table 2). 
Table 2: Psychoactive drugs and their receptors in the brain 
Psychoactive Drugs Receptor 
Marijuana Cannabinoid 
Alcohol GABA 
PCP, LSD, Hallucinogens NMDA, D2 
Opioids Opioid receptor 
Sedatives, hypnotics, and anxiolytics GABA  
Cocaine, methamphetamine, stimulants Dopamine Transports 
Tobacco Nicotine 
 
People with substance use disorder and addiction have an intense focus on a 
particular substance to the point that it overtakes their life. Many times, people with 
substance use disorders report a loss of control in their life as a result of their substance 
use. Substance use disorders are characterized by pathological use of a drug that is not 
medically indicated, in spite of negative consequences for the person who is using the 
drug. These negative consequences include failing to meet work or family obligations or 
repeatedly experiencing interpersonal conflicts or legal problems. Interpersonal conflicts 
and legal problems contribute to the stigmatizing nature of substance use disorders.  
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Substance use disorders alter the brain chemistry and neural circuitry patterns and 
make it difficult to stop using the drug.16 The development of a substance use disorder is 
a complex interplay between both genetic and environmental factors. Due to this complex 
interplay, adequate treatments for substance use disorder are multifaceted and must 
address the brain chemistry, neuronal circuitry, and the person’s social circumstances in 
order to be successful. Although there are many different drugs of abuse, the drugs of 
abuse all converge on the same pathways in the brain. Drugs of abuse mainly affect the 
mesolimbic dopamine system, known as the reward pathway. This activation involves 
increased firing of dopamine neurons in the ventral tegmental area of the midbrain and a 
subsequent increase of dopamine released into the nucleus accumbens  (also called the 
ventral striatum) and other regions of the limbic forebrain (for example, the prefrontal 
cortex).16 Drugs of abuse strengthen this pathway in ways that natural stimulators cannot, 
which contributes to the pathology of addiction.  
Substance use disorders qualify as chronic disease processes due to the chronic, 
relapsing nature of substance dependence. Substance use disorders can be likened to such 
diseases as hypertension or diabetes where tight control of the symptoms proves 
challenging and patients are at times noncompliant. However, patients with substance use 
disorders or substance dependence are rarely viewed through this lens. This could be 
multifactorial and possibly related to the voluntary initiation of substance misuse.17 
Educating medical trainees regarding the disease process of substance use and substance 
dependence could help decrease the stigma of addiction.  
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In 2015, an estimated 27 million Americans aged 12 or older were current 
(defined as within the past month) illicit drug users.1 This estimate represents 10.1 
percent of the population aged 12 or older. More than 52 percent of Americans report 
being current drinkers of alcohol.1 In 2015, an estimated 20.8 million persons aged 12 or 
older (8.2 percent) were classified with substance use disorder.  Of these, 15.7 million 
people had an alcohol use disorder and 7.7 million had an illicit drug use disorder.1 The 
prevalence of these behavioral health disorders affect millions of adolescents and adults 
in the US and contributes substantially to the burden of disease as substance use disorders 
have a myriad of negative health effects and consequences.18 Because of this increase in 
the burden of disease in this population, PA students should be familiar with the 
conditions and treatment options in order to more optimally and empathetically care for 
this population.  
Nationally, the opioid epidemic has reached new heights in the past twenty years. 
Since 1999, prescription opioid overdose deaths have quadrupled.19 Some estimate that 
almost 17,000 deaths per year are related to opioid use. In the United States, roughly 
400,000 people were considered current heroin users within the past month.1 
Additionally, 4 million people have reported using prescription opiates for nonmedical 
reasons.1 As Physician Assistant students in Massachusetts, it is of particular importance 
to recognize and offer help to those suffering with opioid use disorder. Massachusetts 
continues to have an increase in the number of opioid related deaths each year. Figure 1 
demonstrates the rise in deaths related to opioids since 2000. This study hopes to make 
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students more aware of the burden and nature of substance use disorders in order to more 
effectively treat and decrease the stigma surrounding these disorders. 
	  
Figure 1: Opioid Related Deaths January 2000-June201620 
Substance use disorders place a burden on the economy. According to the Office 
of National Drug Control Policy, substance use disorders place a burden on the 
workforce, health care system, and communities.21 The economic cost of substance abuse 
was estimated to be $193 billion in 2007.21 Of this $193 billion, $120 billion was 
estimated to be due to lost productivity that included labor participation costs, 
participation in drug abuse treatment, incarceration, and premature death. $11 billion was 
attributed to healthcare cost, which included drug treatment and drug-related medical 
consequences. Lastly, $61 billion derived from criminal justice costs due to criminal 
investigation, prosecution, and incarceration.21 Substance use disorders are both prevalent 
and carry high societal costs. Decreasing stigma around these disease processes could 
help people begin treatment at an earlier time point and thus decrease both the economic 
cost as well as the human cost of the disease.  
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 Because the opioid epidemic has reached new heights, Governor Baker of 
Massachusetts has placed a heavy emphasis on educating medical trainees on the 
prevention and management of prescription drug misuse.  Physician Assistant educators 
in Massachusetts, the Massachusetts Department of Public Health, and the governor’s 
office, created core competencies for educating physician assistant student trainees on 
opioid misuse prevention.  The core competencies address different domains of substance 
use disorders. The primary prevention domain aims to educate physician assistant 
students on how to screen, evaluate, and prevent prescription drug misuse. The secondary 
prevention domain aims to treat patients at-risk for substance use disorders. The tertiary 
domain aims to manage substance use disorders as chronic diseases and to eliminate the 
stigma of substance use disorders.22 This study hopes to develop a curriculum to 
emphasize the tertiary domain of the core competencies. In order to effectively treat and 
decrease the stigma of substance use disorders, physician assistant students need to be 
educated before they enter their clinical realms on substance use disorders.  
Although substance use disorders are prevalent and encountered in practice each 
day, stigma still surrounds substance use disorders. Stigma is defined as a mark-
signifying deviance and by the presence of a deeply discrediting attribute.3,4 This mark 
signifying deviance could be anything that is considered undesirable according to society. 
In other words, it is an exclusion based on a negatively viewed trait. Two manifestations 
of stigma exist: external or public and internalized.  External or public stigma is defined 
as the negative beliefs people in society have about people in stigmatized groups for 
example, mentally ill patients, patients with substance use disorders, homosexuals. 
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Internal stigma is defined as the devaluation that people in stigmatized groups hold about 
themselves in relation to the rest of society.6 Stigmatizing or biased attitudes of health 
professionals toward patients with substance use disorders could affect health care 
delivery in this population, resulting in treatment avoidance or relapse.7,8 As a 
consequence of stigma, individuals with substance use disorders may experience status 
loss or discrimination. This status loss can affect many realms of the person’s life 
including housing, job opportunities, and access to and utilization of care.  
Several studies demonstrated that the influence of training and education on 
health professionals’ attitudes toward patients was suboptimal and led to feelings of 
inadequacy in both knowledge and skills to manage substance abuse patients.9,10  It also 
demonstrated that this lack of training and education led to more negative regard toward 
patients with substance use disorders.12 The goal of this study is to educate PA students 
prior to their clinical year about substance use disorders in order to minimize provider 
stigma toward with these disorders.  
van Boekel describes stigma as a process that starts when a group of persons is 
labeled based upon characteristics; for example, substance use disorder or mental illness. 
Stigmatized people are then linked to undesirable characteristics or stereotypes and 
experience status loss or discrimination.23 People with substance use disorders experience 
stigma and negative bias, which adversely impacts their decision to seek treatment. In the 
United States, a quarter of people with lifetime alcohol dependence and thirty eight 
percent of patients with drug dependence received treatment for their condition. 24,25 The 
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impact of stigma in patients with substance use disorder impacts many realms of their 
life, including their decision to seek treatment and utilize healthcare. 
The foundational work on stigma and its effects started studying those with 
mental illness.  In a study in 2001 by Corrigan et al, it was hypothesized that less 
familiarity with mental illness led to increased levels of prejudice and stigma.14 In this 
study the authors present a model for how people approach those with stigmatized 
conditions, in this case mental illness (Figure 2). Path analysis was used to test the fit of 
the model proposed. In order to explain the path toward discrimination, familiarity and 
ethnicity were studied as factors linked to discrimination or social distance. Social 
distance or the ability to avoid certain groups was used as a proxy for discrimination in 
this study. Familiarity with mental illness has been described as knowledge and 
experience with mental illness. Based on prior research, there has been an inverse 
relationship between familiarity and discrimination, meaning that when people are less 
familiar with a given condition, more stigma is likely. Ethnicity also affects prejudice 
toward and discrimination of mentally ill patients. Patients with mental illness from a 
majority group experience stigma less intensely than those patients from a minority 
group.14  
Authoritarianism and benevolence are two different prejudicial attitudes 
previously studied to explain discrimination toward patients with mental illness. 
Authoritarianism means that people will treat those with a stigmatized condition (mental 
illness or substance use disorder for example) as if they are in a class inferior to normal 
persons. Another subset of the population will treat these people with benevolence. 
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Benevolence is defined as kindness to “unfortunates.” This is similar to how parents treat 
children and is patronizing in nature. Both of these behaviors result in social distance, 
which in this study was used as a proxy for discrimination. Figure 2 demonstrates the 
hypothesized model for discrimination and social distance toward patients with mental 
illness. After path analysis, it can be concluded that the model had a good fit. The study 
was limited by its relatively small sample size (151) and the fact that a majority of the 
respondents were white females, which limits its generalizability. However, the study 
posits that more training and educational programs could be beneficial to decrease stigma 
as the inverse relationship between familiarity and social distance was confirmed in their 
path analysis.14 
 
 
Figure 2: Path models to discrimination, taken from Corrigan et. al, 2001 
 This group continued their work and wove attribution theory into the framework 
of stigma for those with mental illness. In a study in 2003, they analyzed the causal 
attributions for mental illness. Causal attribution beliefs, or the process by which 
individuals explain the causes of behavior and events, affects how providers view 
patients with stigmatized conditions.26 This study found that when subjects attributed the 
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cause of mental illness to be under one’s control, perceptions of dangerousness increased, 
withholding help increased, and avoidance increased.26 Although patients with substance 
use disorder are distinct from those with mental illness, the populations overlap and the 
avoidance, feelings of dangerousness, and perceptions of controllability of the disease 
processes are similar. Attributing controllability to these disease processes increases the 
stigmatizing nature of the condition. 
 In order to better characterize public stigma toward substance use disorders, 
Janulis et al adapted a model used to explain stigma toward mental illness. The 
researchers hypothesized that perceptions of dangerousness play a key role in the 
stigmatization of patients with substance use disorders.  The study utilized the familiarity 
model of desired social distance and applied it to three substance use disorders including 
alcohol dependence, marijuana dependence, and heroin dependence (Figure 3).5  
 
Figure 3: Theoretical path model of familiarity, taken from Janulis et al 2013  
In this study, participants were recruited from a psychology subject pool at a 
medium-sized mid-western university. A cross sectional survey was administered to 
university students to measure the four variables in the model presented (familiarity, 
perceived dangerousness, fear, and social distance). The researchers then took the data 
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and used path analysis to measure the fit to the proposed model. According to their 
results, the model showed excellent fit for alcohol, marijuana, and heroin.5 Both 
perceived dangerousness and fear were significantly related to desired social distance 
from alcohol, marijuana, and heroin. Familiarity or the participants’ knowledge and 
experience with substance use disorders was significantly related to perceived 
dangerousness for marijuana and heroin but not alcohol.5 In general this study validated 
the efforts to expand mental health stigma research to substance use disorder stigma 
research. However, the study had several limitations. Having subjects respond to a survey 
where individuals are labeled as “addicted” could give more dramatic or exaggerated 
responses than to a vignette scenario. The study also obtained data using cross sectional 
data, which is a limited study design. However, this study posited that familiarity with 
substance use disorders, specifically alcohol, marijuana, and heroin use disorders would 
decrease social distance or discrimination.   
Existing research 
A number of studies document the attitudes of clinicians toward patients with substance 
use disorders. Generally, clinicians and health professionals have negative attitudes 
toward patients with substance use problems.10,12,13,27 Negative attitudes of clinicians 
towards substance abuse patients leads to lack of empowerment for these patients and 
poorer treatment outcomes.28 A study by Gilchrist et al in 2011 demonstrated that 
clinicians’ regard for working with patients with substance abuse disorders was lower 
than working with patients with diabetes or depression.29 This study used a multi-center, 
cross-sectional comparative study design to compare physician regard for working with 
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four different patient groups. In this study, regard for working with alcohol (mean score 
alcohol: 45.35, 95% CI 44.76, 45.95) and drug users (mean score drugs: 43.67, 95% CI 
42.98, 44.36) was consistently lower than for other patient groups (mean score diabetes: 
50.19, 95% CI 49.71, 50.66; mean score depression: 51.34, 95% CI 50.89, 51.79).29 This 
study, however, is limited by the fact that the researchers used convenience sampling for 
the population interviewed in this study. Although the study was limited by this method 
of sampling, one of the strengths of the study was that it had a very high sample size (886 
staff). This study is also notable for demonstrating that physicians in primary care held 
lower regard for working with patients with drug and alcohol users than specialists who 
work with these patients regularly, indicating that familiarity with the disease process 
increased regard for working with this population.	  
Another study that focused on attitudes of nurses demonstrated that the nurses felt 
a lack of motivation and decreased levels of satisfaction when working with patients with 
substance use disorders.30 In this study, nurses felt that their therapeutic attitude, or their 
willingness to engage and provide care for patients, toward working with patients with 
substance use disorders was lower than their therapeutic attitude toward working with 
patients with other disease processes.30 A similar study measuring therapeutic attitude 
among clinicians working with patients with substance use disorders demonstrated that 
increased therapeutic commitment was related to the level of education and experience 
the providers had with substance users.31 The model developed in this study suggested 
that education and knowledge about substance use disorders helped increase therapeutic 
commitment and therapeutic attitudes toward working with patients with substance use 
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disorders.31 Increasing education and training about substance use disorders could help 
mitigate these negative attitudes and stigma toward substance users. 
	   Additionally, several studies demonstrated that health professionals who had more 
personal or work experience with substance use disorders reported more positive attitudes 
working with this population. In a study by Brener et. al, 60 health care workers and 120 
of their clients with hepatitis C virus (HCV acquired from injecting drug use) were 
administered attitude surveys to deduce whether greater contact with HCV-positive 
patients would result in more positive attitudes toward working with this patient 
population from the health care providers.27 This population included both physicians and 
nurses. Overall health care workers had positive explicit attitudes towards their HCV-
positive clients with injection drug use, M= 62.98, SD= 19.4, as demonstrated by the fact 
that this value was greater than the feeling thermometer scale midpoint of 50, t (59) = 
5.18, p< .001.27 This study concluded that increased contact and familiarity with people 
who inject drugs (PWID) led to more positive attitudes toward this patient population.  
 Clinicians and providers who are more familiar with substance use disorders are 
more positive toward their treatment options as well. A study administered the substance 
abuse attitude survey to health care providers working with substance use disorder 
clients. 173 completed the questionnaires. The study found that a greater proportion of 
the survey respondents held positive views on treatment interventions. The respondents 
also felt that substance use disorders are treatable illnesses and likened them to chronic 
diseases. The majority of the survey respondents also held non-discriminatory attitudes 
towards drug-dependent people.32 This study demonstrated optimistic attitudes toward 
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different treatment and management options for substance use disorders. Although this 
study has a generally positive view of patients with substance use disorders, its 
generalizability is limited as the majority of respondents to the survey were nurses 
working with substance users.  
 In order to explain the negative attitudes toward working with patients with 
substance use disorders, several studies were completed. A qualitative study by Ford et al 
in 2011 analyzed how nurses felt when caring for patients with substance use disorders. 
In this study, a survey was administered to a sample of nurses in Australia who worked 
with PWID. The study found that nurses who worked with this population found the 
PWID to be emotionally challenging and potentially unsafe.33 In addition, they felt that 
PWID could be potentially violent, manipulative, and irresponsible and this led to 
negative attitudes or stigma toward this patient population.33 Similarly, a study of general 
practitioners demonstrated that these clinicians found patients with substance use 
disorders to be manipulative aggressive, rude, and poorly motivated.10 In this study, a 
multifaceted survey was administered to general practitioners in the greater London area. 
The study received a 54% response rate. The results were notable for general 
practitioners having concerns regarding violence among this population. It also 
demonstrated a concern about the problem of opiate misuse and their responsibility to 
detect this problem early so as to not have issues with their practice.10 
 Controllability of the addiction disease process also played a role in how 
clinicians viewed patients with substance use disorder. Studies have demonstrated that 
causal attributions such about the controllability of addiction lead to the generation of 
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more stigmatizing attitudes toward substance misusers.14,26 Brener et al validated these 
theories in a study in 2010.  In this study, a sample of 60 health care workers was 
recruited from services that attracted PWID. These services included needle and syringe 
exchange programs, methadone clinics, and drug user treatment facilities. This study 
demonstrated that perceptions of high controllability over injecting drug use contributed 
to the negative attitudes held by health care workers toward PWID.34 This is likely due to 
the fact that if people can attribute controllability to addiction, then it is easier to place 
blame on the person with substance use disorders or substance dependence. This is in 
contrast to other disease processes, for example, hypertension, where people don’t 
necessarily attribute controllability. This increases the stigma of addiction. In order to 
combat this, earlier educational interventions regarding addiction as a chronic disease 
need to be implemented. 
 The stigmatization of patients with substance use disorders affects health care 
delivery in this patient population. Although there have been relatively few studies in this 
area, the data demonstrates that patients who felt marginalized or discriminated had 
poorer outcomes. For example, Brener demonstrated that patients who reported greater 
perceived discrimination by health professionals were less likely to complete treatment.35 
In this study, clients from residential drug rehabilitation facilities in Sydney, Australia 
were administered a series of quantitative measures assessing drug history, severity of 
drug use, treatment history, perceptions of staff discrimination, and treatment motivation. 
These clients were then followed up with regularly until either dropout or treatment 
completion occurred. This study found that perceptions of discrimination were a major 
	  20 
detriment to treatment completion and this was statistically significant.35 This study 
highlights that staff client interactions can greatly impact the success of an addiction 
treatment plan. Perceptions of discrimination, stigmatization, and social isolation impact 
relapse rates and treatment completion. Another study by Brener showed that clients 
viewed their providers more positively if the providers expressed more positive attitudes 
toward them.27 In this study, both HCV-positive injection drug users and health care 
workers were sampled with attitude surveys to assess their implicit and explicit biases 
and attitudes toward one another. It found that those users with more contact with 
providers with positive attitudes held more positive views of treatment and healthcare. 
This is important because patients with positive views of healthcare and patients with 
substance use disorders who do not feel stigmatized are more likely to complete their 
treatment.   
  A major contributing factor to the continuation of stigma could be provider 
education regarding substance use disorders. Several studies have examined how levels 
of education and training affect health professionals’ attitudes toward patients with 
substance use disorders. Generally, the studies demonstrate that health professionals have 
low proficiency about substance use disorders and feel that they lack the level of 
expertise required to care for this population. In a study by McLaughlin et al in 2006, 
health or social work practitioners were surveyed regarding their views on working with 
patients with substance use disorders. The survey targeted community settings in 
Northern Ireland. Thirty-five social and health professionals participated in the study. 
The participating health professionals reported having little to no in service education or 
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training in the care and treatment of illicit drug users. Some providers even admitted that 
they would reject training to minimize contact with illicit drug users. Another theme that 
emerged from this study was that practitioners felt that if they did receive more training 
that the “drug addicts” would then be diverted to them and they felt this was not 
beneficial to their practice. Many of the providers surveyed expressed strongly negative 
views of this patient population and stated their preference not to care for this population 
at all. One general practitioner in this study stated that “a lack of education about the 
illicit drug problem was central to a lot of the difficulty health and social care 
professionals have in this area.”13 Although this study highlighted education deficits 
regarding illicit drug use, the study is limited in its design. For one, the study used 
purposive sampling. This means that respondents were selected according to whom the 
researchers felt were appropriate for the study. In other words, the sample was not a 
random selection of general practitioners in Northern Ireland. Additional limitations to 
this study include the small sample size that was actually used to glean these opinions. 
The major conclusion, however, was that potentially increasing education and giving 
practitioners the education necessary to care for this patient population is crucial in order 
to eliminate provider stigma. 
 Likewise, HIV-infected injection drug users and their primary HIV physicians 
completed a cross sectional survey regarding their attitudes. In this study, the researchers 
evaluated physicians’ training, experience, and practice characteristics and analyzed how 
these variables affected their attitudes toward PWID.11 This study found significant 
differences in attitudes among physicians with different levels of expertise (p=.02). 
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General medicine physicians who were non-experts in HIV treatment had the most 
negative attitudes. Infectious disease specialists had the most positive attitudes. 
According to this study, greater physician knowledge about HIV treatment was 
associated with less negative attitudes (p<.001).11 This study used data that was collected 
during an early period of the HIV epidemic. This could limit the value of the study as 
attitudes and knowledge of care for HIV-infected PWID could have changed and could 
affect the views of the physicians in this article.  
 PAs are expected to work in a vast array of settings. The ability to identify and 
offer treatment to patients with substance use disorders cannot be overstated. In order to 
combat stigma among providers, earlier educational interventions need to be put in place 
before they enter clinical practice. 
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METHODS  
Study design 
This curriculum titled, “Substance Use Disorders and Associated Stigma”, is a module 
that will teach PA students the definition of substance use disorders, treatment options for 
different substance use disorders, the definition of stigma, and how to decrease provider 
stigma regarding substance use disorders. Students will explore their own personal biases 
toward patients with substance use disorders. By participating in this module, PA 
students will decrease their own stigma toward this patient population. The study will 
include an analysis of students’ attitudes toward patients with substance use disorders.  
 
Study population and sampling 
The study population will consist of pre-clinical PA students at Boston University School 
of Medicine Physician Assistant Program who are at the end of their didactic training. 
The PA program enrolls roughly 30 students each class. All of the students will be invited 
to participate in the curriculum module. The sample size will be approximately 30 
students which will yield an estimated statistical power of 86% assuming a test average 
of 3, a sample average of 3.5 and a standard deviation of 1 point.36 
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Intervention 
	  
Figure 4: Substance Use Disorders and Associated Stigma Intervention Design 
The intervention is to teach PA students about substance use disorders in a more 
comprehensive way than just lectures alone. The information will be taught using video 
vignettes from Scope of Pain, a lecture, and student group discussions. The vignettes will 
include patients with different substance use disorders interacting with different health 
care providers. Students will watch and respond to the vignettes after the lecture on 
substance use disorders and stigma. They will be asked to diagnose the specific substance 
use disorder and answer questions about how they would feel treating the patient in a 
given vignette. Students will be asked to complete a pre- and post- module Substance 
Abuse Attitude Survey as well as post-module questionnaires to evaluate the efficacy of 
the educational intervention.37 
 The module will be implemented during the Clinical Practicum Course in the 
spring semester of the didactic year. The intervention will begin with all of the students 
completing a pre-module Substance Abuse Attitude Survey (SAAS) (Table 3).  The 
Substance Abuse Attitude Survey consists of 50 attitude statements and uses a five-point 
Likert-scale for indicating degrees of agreement or disagreement. It measures attitudes on 
five factors: non-stereotyping, permissiveness, non-moralism, treatment optimism, and 
treatment intervention.37 The study author will then present the students with a lecture 
SAAS	   Lecture	   Video	  vignettes	  and	  short	  answer	   Group	  Discussion	   First	  rotation	   Repeat	  SAAS	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defining different substance use disorders, outlining their treatment, and defining stigma. 
At the end of the session, the learner will be able to: 
I. Define substance use disorder according to DSM V criteria 
II. Provide different treatment options for different substance use disorders 
III. Define external stigma, stereotypes, bias or prejudice, discrimination, and 
identify personal sources of these components 
IV. Identify various ways in which drug users experience stigma through 
group discussion  
V. Brainstorm ways to address stigma at personal and societal levels 
VI. Explain how stigma represents a barrier to treatment for patients with 
substance use disorder 
After the completion of the video vignettes, students will also have small group 
discussions to discuss their own personal biases/prejudices toward patients with 
substance use disorders. They will examine some of the personal biases they wrote down 
in response to the videos. The study author will facilitate the discussions between 
different student groups. They will also complete a survey to analyze the effectiveness of 
the educational intervention. On the first call back day of their first clinical rotation, the 
students will retake the SAAS to see if their attitudes about patients with substance use 
disorders have changed. (See Appendix)  
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Study variables and measures 
All students will be asked to take the substance abuse attitude survey both before and 
after the completion of their first rotation. Students will also complete a questionnaire in 
which they will evaluate the benefit of the clinical vignettes, the lecture, and the student 
group discussions about stigma using both a Likert-scale of 1-5 and open ended 
questions. They will also be asked how likely they are to incorporate the information they 
learned during this session into their practice.  
 
Recruitment 
All Boston University Physician Assistant Students enrolled in the didactic year of 
training will be approached for participating and consenting to the study.  Students will 
participate in the same curriculum and their participation will be voluntary. 
Data collection 
Data will be collected using the SAAS, which is a 50-question Likert-scale type survey. 
Responses to the vignettes will also be recorded using an online survey system such as 
RedCap. Students will also respond to a Likert-scale to analyze the efficacy of the 
educational intervention. 
 
Data analysis 
Data from the pre- and post module SAAS will be analyzed using a paired t-test 
analyzing the mean change and standard deviation among the survey items The Likert 
scale questionnaire will be analyzed for mean item scores with standard deviation to 
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assess students’ evaluation of the module and to make changes to the module in the 
future. 
 
Timeline and resources 
Table 3: Timeline for the Substance Use Disorders and Associated Stigma 
Curriculum 
Summer 2017 • IRB submission and approval 
• Development of content for substance use disorder lecture 
Fall 2017 • Develop patient vignettes  
• Develop Likert scale module evaluation 
Spring 2018 • Substance Abuse Attitude Survey 
• Lecture on substance use disorders 
• Student group discussion 
• Post-module Likert scale evaluation 
• Study completion 
Summer 2018 • Data Analysis 
• Manuscript submission 
 
Table 4: Budget for the Substance Use and Associated Stigma Curriculum 
Line Item 
Administrative Support 
• Clerical 
• Data Entry 
• Statistical Consulting 
Supplies and Expenses 
• SAAS 
• RedCap 
• Scope of Pain Resource Videos 
Communication 
• Email 
• Meetings 
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Institutional Review Board 
The study will be submitted to the Boston University Medical Campus IRB for review for 
exemption for educational studies under 45 CFR 46.101 (b) criteria. If the study is not 
approved, a full IRB protocol will be submitted for expedited review.  	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CONCLUSION 
Discussion 
This study focuses on PA student biases and stigma toward patients with substance use 
disorders. The goal of the study is to help students more deeply understand substance use 
disorders as chronic diseases in order to decrease stigma and bias toward patients with 
these conditions.  After completing the module and before entering the clinical portion of 
physician assistant student training, the student will be able to understand how stigma 
affects patients with these conditions. This study is unique because it focuses heavily on 
stigma and individual student bias toward patients with substance use disorders before the 
students begin their clinical training. 
This study, although unique in the sense that it focuses on stigma as it relates to 
both substance use disorders and physician assistant students, has several limitations. 
First, the sample size of physician assistant students participating in the study is small. 
The class size of the Boston University Physician Assistant Program is roughly 30 
students per year. Another limitation of this study is that it relies on honest reporting of 
the students in response to the video vignettes. In order to effectively discuss and analyze 
the student attitudes toward working with patients with substance use disorders, the 
students need to honestly report their feelings in response to the video vignettes.  
This module could be incorporated into other Physician Assistant Program 
curricula throughout the country. Physician Assistants are tasked to take care of a diverse 
patient population and over the course of a career will have to treat and care for a number 
of patients with substance use disorders. The need for a curriculum to help students care 
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for patients with these disorders without stigmatizing the disorders is extremely 
important.  
 
Summary 
With the prevalence of opioid use disorders rising in several states throughout the 
country, the importance of recognizing and treating patients long term with substance use 
disorders continues to grow in importance. Studies have highlighted that with increased 
familiarity and education about substance use disorders, providers have better attitudes 
and decreased stigma toward working with patients with substance use disorders. This 
leads to better provider-patient interactions and better treatment outcomes long term. 
Additionally, research indicates that when substance use disorders are viewed as chronic 
diseases, there is a decrease in the stigma of the disorders. Although many studies 
highlight that familiarity decreases stigma and improves attitudes toward working with 
these populations, little research exists on how to implement effective curricula to help 
mitigate medical trainee stigma before they begin their clinical training. This study hopes 
to explore substance use disorders and associated stigma more deeply than lecture alone. 
It hopes to frame substance use disorders as a chronic disease in an effort to improve 
health care delivery in the patient population with substance use disorders. 
The effects of stigmatizing patients with substance use disorders results in poor 
health care delivery, poorer treatment outcomes, and marginalization of this patient 
population. Familiarizing students with different substance use disorders and delving into 
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their personal biases toward this patient population could help mitigate their stigma 
toward this population before they enter the clinical portion of their training.  
 
Clinical and/or public health significance 
Throughout the course of a PAs career, they will encounter countless individuals with 
substance use disorders. The ability to care for these patients with empathy and 
understanding will help improve care for these patients. The best ways to teach physician 
assistant students how to effectively and empathetically treat patients with different 
substance use disorders have not been extensively studied. This curriculum has been 
created to educate PA students on the definition of substance use disorders and to help 
and encourage PA students to explore their own personal biases toward patients with 
substance use disorders. This curriculum can be easily adopted at other institutions. The 
hope is that by completing this curriculum students will have a deeper understanding of 
substance use disorders and will have the confidence and competency to manage these 
patients without bias or stigma.  
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APPENDIX 
Substance Abuse Attitude Survey 
Item   Answer Choices (Circle one) 
Factor I: Non-Stereotyping 
People who use marijuana usually do not 
respect authority 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Smoking leads to marijuana use, which, in 
turn, leads to hard drugs 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Anybody who is clean shaven with short 
hair probably doesn’t use illegal drugs 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
People who dress in hippie-style clothing 
usually use psychedelic drugs 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Marijuana use leads to mental illness Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Heroin is so addicting, that no one can 
really recover once he/she becomes an 
addict 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
All heroin use leads to addiction Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Weekend users of drugs will progress to 
drug misuse 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
A hospital is the best place to treat an 
alcoholic or drug addict 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Recreational drug use precedes drug 
misuse 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Factor II: Permissiveness 
Marijuana should be legalized Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Marijuana use among teenagers can be 
healthy experimentation 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Personal use of drugs should be legal in the 
confines of one’s own home 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Daily use of marijuana is not necessarily 
harmful 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Tobacco smoking should be allowed in 
high schools 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
It can be normal for a teenager to 
experiment with drugs 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Persons convicted of sale of illicit drugs 
should not be eligible for parole 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Lifelong abstinence is a necessary goal in 
the treatment of alcoholism 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
	  33 
Once a person becomes drug-free through 
treatment he can never become a social 
user 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Parents should teach their children how to 
use alcohol 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Factor III: Non-moralism 
A physician who has been addicted to 
narcotics should not be allowed to practice 
medicine again 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Clergymen should not drink in public Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Street pushers are the initial source of 
drugs for young people  
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Alcohol is so dangerous that it could 
destroy the youth of our country if it were 
not controlled by law 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Angry confrontation is necessary in the 
treatment of alcoholics or drug addicts 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Chronic alcoholics who refuse treatment 
should be legally committed to long-term 
treatment 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Alcohol and drug misusers should only be 
treated by specialists in the field 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Alcoholism is associated with a weak will Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Using any hard drugs shortens one’s life 
span 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
The laws governing the use of marijuana 
and heroin should be the same 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
 
 
Factor IV: Treatment Optimism  
Drug addiction is a treatable illness Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Alcoholism is a treatable illness Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
An alcohol- or drug- dependent person 
who has relapsed several times probably 
cannot be treated  
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Most alcohol- and drug-dependent persons 
are unpleasant to work with as patients 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
An alcohol- or drug-dependent person 
cannot be helped until he/she has hit “rock 
bottom” 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Factor V: Treatment Intervention  
Physicians who diagnose alcoholism early 
improve the chance of treatment success 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
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Family involvement is a very important 
part of the treatment of alcoholism or drug 
addiction 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Street pushers are the initial source of 
drugs for young people  
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
The best way for a physician to treat 
alcohol- or drug dependent patients is to 
refer them to a good treatment program 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Group therapy is very important in the 
treatment of alcoholism or drug addiction 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Urine drug screening can be an important 
part of treatment of drug misuse 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Long-term outpatient treatment is 
necessary for the treatment of drug 
addiction 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Once an alcohol- or drug-dependent patient 
is abstinent and off all medication, no 
further contact with a physician is 
necessary 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
Paraprofessional counselors can provide 
effective treatment for alcohol or drug 
misusers 
Strongly Agree  Agree  Neutral  Disagree  Strongly Disagree 
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